Emily Cendrowski, MD
Interventional Cardiology · Saint Louis, MONPI 1124481577
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Edwards Lifesciences at 53.7% of the total. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.
Across 94 payments — averaging $80.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$4K
- Abbott$2K
- Abiomed$728
- Boston Scientific$216
- Shockwave Medical, Inc$169
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$113
- plus $469 from 12 others
What the payments were for
- Travel & lodging$4,12954%
- Food & beverage$3,47246%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 39 | $4,081 |
| Abbott | 17 | $1,825 |
| Abiomed | 9 | $728 |
| Boston Scientific | 5 | $216 |
| Shockwave Medical, Inc | 1 | $169 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $113 |
| Philips North America LLC | 1 | $103 |
| Siemens Medical Solutions USA, Inc. | 6 | $100 |
| Medtronic | 3 | $87 |
| Kestra Medical Technology Services, Inc. | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Cvrx, Inc. | 1 | $20 |
| Amgen | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Merck | 1 | $15 |
| Heartflow, Inc. | 1 | $14 |
| Getinge USA Sales, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,602 in reported general payments places this provider in the 40th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $11,695 |
| Rosuvastatin Calcium | 12 | $165 |
| Atorvastatin Calcium | 16 | $151 |
| Metoprolol Succinate | 20 | $124 |
| ClopidogrelClopidogrel Bisulfate | 15 | $70 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Saint Louis
- John LasalaSaint Louis$936K
- Harvey SerotaSaint Louis$752K
- Jasvindar SinghSaint Louis$696K
- Alan ZajariasSaint Louis$203K
- Anish ThomasSaint Louis$171K
- Gus TheodosSaint Louis$165K
- Prashanth ThakkerSaint Louis$129K
- Marc SintekSaint Louis$119K
- George KichuraSaint Louis$118K
- Gil VardiSaint Louis$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.